A single nucleotide polymorphism in the STAT5 gene favors colonic as opposed to small-bowel inflammation in crohn's disease

Diseases of the Colon and Rectum

Volumn 56, Issue 9, 2013, Pages 1068-1074

  Connelly, Tara M ^a   Koltun, Walter A ^a   Berg, Arthur S ^a   Hegarty, John P ^a   Brinton, David ^a   Deiling, Sue ^a   Poritz, Lisa S ^a   Stewart, David B ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Crohn's disease; Genetics; Phenotype; Polymorphism; SNP; STAT5

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; STAT5 PROTEIN;

ADULT; ALLELE; ARTICLE; CROHN DISEASE; FEMALE; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; COHORT STUDIES; COLITIS; CROHN DISEASE; FEMALE; GENETIC MARKERS; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; ILEITIS; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; STAT5 TRANSCRIPTION FACTOR; YOUNG ADULT;

EID: 84884471531     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31829de128     Document Type: Article

References (22)

1. Patil SA, Cross RK. Update in the management of extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep. 2013;15:314.
2. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753. (Pubitemid 43764536)
3. Yamamoto T. Strictureplasty or resection for small-bowel Crohn?s disease? Dis Colon Rectum. 2012;55:e382-e383.
4. Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology. 2011;140:1704-1712.
5. Lee J, Parkes M. 100 genes for IBD?Whatever next!? IBD Monitor. 2011;11:103-111.
6. Amoli MM, Carthy D, Platt H, Ollier WE. EBV immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood. Int J Epidemiol. 2008;37(suppl 1):i41-i45.
7. National Center Biotechnology Information, National Institutes of Health. dbSNP short genetic variation. http://www.ncbi.nlm.nih. gov/SNP/snp-ref.cgi?rs= 16967637. Accessed February 2, 2013.
8. Piazza F, Valens J, Lagasse E, Schindler C. Myeloid differentiation of FdCP1 cells is dependent on Stat5 processing. Blood. 2000;96:1358-1365. (Pubitemid 30658464)
9. Snow JW, Abraham N, Ma MC, Herndier BG, Pastuszak AW, Goldsmith MA. Loss of tolerance and autoimmunity affecting multiple organs in STAT 5A/5B-deficient mice. J Immunol. 2003;171:5042-5050. (Pubitemid 37432785)
10. Pandiyan P, Yang XP, Saravanamuthu SS, et al. The role of IL-15 in activating STAT 5 and fine-tuning IL-17A production in CD4 T lymphocytes. J Immunol. 2012;189:4237-4246.
11. Liao W, Lin JX, Wang L, Li P, Leonard WJ. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat Immunol. 2011;12:551-559.
12. O?Shea JJ, Lahesmaa R, Vahedi G, Laurence A, Kanno Y. Genomic views of STAT function in CD4+ T helper cell differentiation. Nat Rev Immunol. 2011;11:239-250.
13. Budagian V, Bulanova E, Paus R, Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 2006;17:259-280. (Pubitemid 44038618)
14. Laurence A, Tato CM, Davidson TS , et al. Interleukin-2 signaling via STAT 5 constrains T helper 17 cell generation. Immunity. 2007;26:371-381. (Pubitemid 46413906)
15. Litherland SA, Xie TX, Grebe KM, et al. Signal transduction activator of transcription 5 (STAT 5) dysfunction in autoimmune monocytes and macrophages. J Autoimmun. 2005;24:297-310. (Pubitemid 40775854)
16. Gilbert S, Zhang R, Denson L, et al. Enterocyte STAT 5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation. EMBO Mol Med. 2012;4:109-124.
17. O?Shea JJ, Murray PJ. Cytokine signaling modules in inflammatory responses. Immunity. 2008;28:477-487. (Pubitemid 351467044)
18. Bhat M, Nguyen GC, Pare P, et al. Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository. Am J Gastroenterol. 2009;104:2233-2240.
19. Fernandez L, Mendoza JL, Martinez A, et al. IBD1 and IBD3 determine location of Crohn?s disease in the Spanish population. Inflamm Bowel Dis. 2004;10:715-722. (Pubitemid 39545215)
20. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn?s disease. Gastroenterology. 2002;122:854-866. (Pubitemid 34267267)
21. Hancock L, Beckly J, Geremia A, et al. Clinical and molecular characteristics of isolated colonic Crohn?s disease. Inflamm Bowel Dis. 2008;14:1667-1677.
22. Chen H, Lee A, Bowcock A, et al. Influence of Crohn?s disease risk alleles and smoking on disease location. Dis Colon Rectum. 2011;54:1020-1025.